Ehlers-Danlos Syndrome Expert Witnesses in Rhode Island

This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.

This extremely qualified expert is board certified in internal medicine and rheumatology and has been practicing for 39+ years. He completed both his internship and residency trainings at Long Island Jewish-Hillside Medical Center and his fellowship training in theumatology and immunology at the University of Pittsburgh. He is a past president of the Scleroderma Clinical Trials Consortium and a fellow at the American College of Physicians, the American College of Angiology and the American College of Rheumatology. He has published 235+ peer-reviewed journal articles and serves in the editorial boards of 13 renowned medical journals. He lectures both nationally and internationally and has been listed in "Who's Who in America" for 29 consecutive years, as well as in "Best Doctors in America" for 24 consecutive years. He is the former director of the Scleroderma Program and the former chief of rheumatology at the University of Medicine and Dentistry of New Jersey and the former director of the Clinical Research Center at the NJ Center for Advanced Biotechnology and Medicine. He is also the former director of the Scleroderma Program at the University of Michigan. Currently, he is the founder and principal of a major scleroderma consulting firm.

This qualified expert earned his BS from the Massachusetts Institute of Technology and his MD from Stanford University School of Medicine. He completed his internship and residency in internal medicine at Mt. Sinai Hospital and his fellowships in rheumatology and clinical immunology at Yale University School of Medicine. In addition to being board certified in internal medicine and rheumatology, this expert has extensive experience in clinical work, academia, and the pharmacy industry. Early in his career, he served as an Internist and Chief of Internal Medicine at Westchester Community Health Plan and Chief of Rheumatology at VAMC-Syracuse. He was a Professor at UMDNJ-Robert Wood Johnson Medical School in the Department of Pediatrics, Medicine, and Molecular Genetics and Microbiology. This expert was also the Medical Director of Immunology at Bristol-Myers Squibb's Pharmaceutical Research Institute, Vice President of NovoNordisk's Medical-Science Inflammation Department, and Vice President of Immunology and Rheumatology at Parexel International. Currently, he is a Clinical Professor at a medical school in New Jersey and is President of a firm that provides consultation services in immunology and rheumatology focusing on molecules in development.